Cabergoline tablets 0.25 mg (Sawai), manufactured by Sawai Pharmaceutical, contains Cabergoline. This internal medicine is identified by YJ code 1169011F1044 and has a standard of 0.25 mg 1 tablet.
Cabergoline tablets 0.25 mg (Sawai)
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
